Vivoryon Therapeutics NV (VVY) - Financial and Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Vivoryon Therapeutics N.V. (Vivoryon), formerly known as Vivoryon Therapeutics AG, is a biopharmaceutical company that conducts clinical-stage research and development of new medicines for the treatment of alzheimers disease. The company offers three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase inhibitor that inhibits QC-enzyme for animal models. Vivoryons PBD-C06 is a monoclonal antibody under evaluation which clear toxic pyroglutamate-Abeta in the brain. The companys PQ1565 is a second QC inhibitor in preclinical stage and demonstrated attractive drug-like properties. It also develops a therapeutic approach, dipeptidyl peptidase 4 inhibitors for the treatment of diabetes. Vivoryon is headquartered in Halle, Germany.
Vivoryon Therapeutics NV Key Recent Developments
Jun 29,2021: Vivoryon Therapeutics provides update on financial guidance
Jun 25,2021: Vivoryon Therapeutics announces financial results for the first quarter of 2021 and provides corporate update
Dec 16,2020: Vivoryon Therapeutics new home member state
Nov 30,2020: Vivoryon Therapeutics announces conversion into Vivoryon Therapeutics N.V.
Nov 26,2020: Vivoryon Therapeutics reports third quarter 2020
This comprehensive SWOT profile of Vivoryon Therapeutics NV provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vivoryon Therapeutics NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Vivoryon Therapeutics N.V. (Vivoryon), formerly known as Vivoryon Therapeutics AG, is a biopharmaceutical company that conducts clinical-stage research and development of new medicines for the treatment of alzheimers disease. The company offers three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase inhibitor that inhibits QC-enzyme for animal models. Vivoryons PBD-C06 is a monoclonal antibody under evaluation which clear toxic pyroglutamate-Abeta in the brain. The companys PQ1565 is a second QC inhibitor in preclinical stage and demonstrated attractive drug-like properties. It also develops a therapeutic approach, dipeptidyl peptidase 4 inhibitors for the treatment of diabetes. Vivoryon is headquartered in Halle, Germany.
Vivoryon Therapeutics NV Key Recent Developments
Jun 29,2021: Vivoryon Therapeutics provides update on financial guidance
Jun 25,2021: Vivoryon Therapeutics announces financial results for the first quarter of 2021 and provides corporate update
Dec 16,2020: Vivoryon Therapeutics new home member state
Nov 30,2020: Vivoryon Therapeutics announces conversion into Vivoryon Therapeutics N.V.
Nov 26,2020: Vivoryon Therapeutics reports third quarter 2020
This comprehensive SWOT profile of Vivoryon Therapeutics NV provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vivoryon Therapeutics NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
TABLE OF CONTENTS
Table of Contents
Section 1 - About the Company
Vivoryon Therapeutics NV - Key Information
Vivoryon Therapeutics NV - Overview
Vivoryon Therapeutics NV - Key Employees
Vivoryon Therapeutics NV - Key Employee Biographies
Vivoryon Therapeutics NV - Key Operational Heads
Vivoryon Therapeutics NV - Major Products and Services
Vivoryon Therapeutics NV - History
Vivoryon Therapeutics NV - Company Statement
Vivoryon Therapeutics NV - Locations And Subsidiaries
Vivoryon Therapeutics NV
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Vivoryon Therapeutics NV - Business Description
Vivoryon Therapeutics NV - Corporate Strategy
Vivoryon Therapeutics NV - SWOT Analysis
SWOT Analysis - Overview
Vivoryon Therapeutics NV - Strengths
Vivoryon Therapeutics NV - Weaknesses
Vivoryon Therapeutics NV - Opportunities
Vivoryon Therapeutics NV - Threats
Vivoryon Therapeutics NV - Key Competitors
Section 3 - Company Financial Performance Charts
Vivoryon Therapeutics NV - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
Vivoryon Therapeutics NV, Key Information
Vivoryon Therapeutics NV, Key Ratios
Vivoryon Therapeutics NV, Share Data
Vivoryon Therapeutics NV, Major Products and Services
Vivoryon Therapeutics NV, History
Vivoryon Therapeutics NV, Key Employees
Vivoryon Therapeutics NV, Key Employee Biographies
Vivoryon Therapeutics NV, Key Operational Heads
Vivoryon Therapeutics NV, Other Locations
Vivoryon Therapeutics NV, Subsidiaries
Vivoryon Therapeutics NV, Key Competitors
Vivoryon Therapeutics NV, SWOT Analysis
Vivoryon Therapeutics NV, Ratios based on current share price
Vivoryon Therapeutics NV, Annual Ratios
Vivoryon Therapeutics NV, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Vivoryon Therapeutics NV, Performance Chart
Vivoryon Therapeutics NV, Ratio Charts
Section 1 - About the Company
Vivoryon Therapeutics NV - Key Information
Vivoryon Therapeutics NV - Overview
Vivoryon Therapeutics NV - Key Employees
Vivoryon Therapeutics NV - Key Employee Biographies
Vivoryon Therapeutics NV - Key Operational Heads
Vivoryon Therapeutics NV - Major Products and Services
Vivoryon Therapeutics NV - History
Vivoryon Therapeutics NV - Company Statement
Vivoryon Therapeutics NV - Locations And Subsidiaries
Vivoryon Therapeutics NV
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Vivoryon Therapeutics NV - Business Description
Vivoryon Therapeutics NV - Corporate Strategy
Vivoryon Therapeutics NV - SWOT Analysis
SWOT Analysis - Overview
Vivoryon Therapeutics NV - Strengths
Vivoryon Therapeutics NV - Weaknesses
Vivoryon Therapeutics NV - Opportunities
Vivoryon Therapeutics NV - Threats
Vivoryon Therapeutics NV - Key Competitors
Section 3 - Company Financial Performance Charts
Vivoryon Therapeutics NV - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
List Of Tables
List of TablesVivoryon Therapeutics NV, Key Information
Vivoryon Therapeutics NV, Key Ratios
Vivoryon Therapeutics NV, Share Data
Vivoryon Therapeutics NV, Major Products and Services
Vivoryon Therapeutics NV, History
Vivoryon Therapeutics NV, Key Employees
Vivoryon Therapeutics NV, Key Employee Biographies
Vivoryon Therapeutics NV, Key Operational Heads
Vivoryon Therapeutics NV, Other Locations
Vivoryon Therapeutics NV, Subsidiaries
Vivoryon Therapeutics NV, Key Competitors
Vivoryon Therapeutics NV, SWOT Analysis
Vivoryon Therapeutics NV, Ratios based on current share price
Vivoryon Therapeutics NV, Annual Ratios
Vivoryon Therapeutics NV, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List Of Figures
List of FiguresVivoryon Therapeutics NV, Performance Chart
Vivoryon Therapeutics NV, Ratio Charts
RELATED REPORTS
Vivoryon Therapeutics AG (VVY) - Financial and Strategic SWOT Analysis Review
Vivoryon Therapeutics AG (Vivoryon) is a clinical-stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimers disease. The company offers three pipeline drug candidates
USD 300 View ReportVivoryon Therapeutics AG (VVY) - Financial and Strategic SWOT Analysis Review
Vivoryon Therapeutics AG (Vivoryon) is a clinical-stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimers disease. The company offers three pipeline drug candidates
USD 300 View ReportProQR Therapeutics NV (PRQR) - Financial and Strategic SWOT Analysis Review
ProQR Therapeutics NV (PRQR) - Financial and Strategic SWOT Analysis Review
USD 300 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS